Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

March 2, 2021

Study Completion Date

March 10, 2021

Conditions
Healthy
Interventions
DRUG

GLPG1205 film-coated tablets

Single oral dose of GLPG1205

DRUG

[14C]-GLPG1205 solution for infusion

A 15-minute IV infusion of \[14C\]-GLPG1205

DRUG

GLPG1205 capsules

Single oral dose of GLPG1205 as solid formulation

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galapagos NV

INDUSTRY

NCT04704739 - Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205 | Biotech Hunter | Biotech Hunter